Table 3. The correlation between anti-NY-ESO-1 positivity and the initial symptoms of intrahepatic cholangiocarcinoma.
Initial demonstration | Univariate associations | Multivariate associations | ||
---|---|---|---|---|
Crud Odd ratio | P value | Adjusted Odd ratio | P value | |
Fever | 1.83 (0.78–2.01) | 0.45 | 1.06 (0.69–1.43) | 0.68 |
Abdominal pain | 4.53 (1.29–8.31) | <0.001 | 2.66 (1.10–4.47) | 0.04 |
Nausea | 1.99 (0.61–1.56) | 0.26 | 0.95 (0.48–1.22) | 0.57 |
Emesis | 1.29 (0.81–3.27) | 0.24 | 0.66 (0.79–2.04) | 0.62 |
Jaundice/pruritus | 1.28 (1.30–4.23) | 0.02 | 0.97 (0.80–3.19) | 0.39 |
Anorexia | 1.58 (0.34–5.89) | 0.43 | 1.02 (0.46–3.37) | 0.55 |
Asymptomatic | 1.05 (0.64–5.73) | 0.72 | 0.89 (0.48–4.41) | 0.84 |